Prostate Navigation
1 in 8 men are diagnosed with prostate cancer1
Transrectal ultrasound-guided (TRUS) prostate biopsies carry a concerning 2-6%2 infection rate, with severe complications like sepsis remaining a persistent risk.
Medivis enhances ultrasound-guided procedural care for urological surgery with real-time imaging fusion, optical tracking and spatial workflows.
Prostate Navigation is not yet available for sale, please contact your Medivis representative for additional information.
Compatible with most ultrasound systems.
MRI/US Fusion
Automatic segmentation and fusion of pre-operative MRI with real-time ultrasound imaging can enable surgeons to confidently visualize and target prostate lesions during procedures.
Virtual Monitors
Plug-and-play Integration with most ultrasound systems to display real-time video feeds on an ergonomic virtual monitor for improved comfort and streamline workflow.
Imaging Overlay
Contextually visualize real-time ultrasound data directly superimposed on patient - true to size and scale. Eliminate attention shift with data directly in your surgical view.
Medivis Workstation
Lightweight workstation with 17” touch monitor. Easy maneuverability and storage.
Zero Prostate Cancer Organization: Prostate cancer facts and statistics.
Rudzinski JK, Kawakami J. Incidence of infectious complications following transrectal ultrasound-guided prostate biopsy in Calgary, Alberta, Canada: A retrospective population-based analysis. Can Urol Assoc J. 2014 May;8(5-6):E301-5. doi: 10.5489/cuaj.1751. PMID: 24940454; PMCID: PMC4039591.
In the news.
Medivis Named Fast Company's Most Innovative Companies 2024
Medivis SurgicalAR Named TIME’s Best Inventions of 2023
October 24, 2023
Providence Swedish Advances Brain Surgery and Presurgical Planning with Microsoft HoloLens 2
June 14, 2023
AR Is Coming to the OR
June 13, 2023
See Our Technology
Healthcare advances gradually, then suddenly.